Overexpression of Protein Kinase C α in Swiss/3T3 Cells Reduces The Number of Both High and Low Affinity of the Epidermal Growth Factor Receptors

[1]  J. B. Santon,et al.  Ligand-activated thyroid hormone and retinoic acid receptors inhibit growth factor receptor promoter expression , 1990, Cell.

[2]  N. Shimizu,et al.  TPA induces repression of EGF receptor gene expression , 1990, FEBS letters.

[3]  A. Ullrich,et al.  Overexpression of protein kinase C alpha-subtype in Swiss/3T3 fibroblasts causes loss of both high and low affinity receptor numbers for epidermal growth factor. , 1990, The Journal of biological chemistry.

[4]  I. Weinstein,et al.  Disturbances in growth control and gene expression in a C3H/10T1/2 cell line that stably overproduces protein kinase C. , 1989, Oncogene.

[5]  Y. Nishizuka,et al.  The molecular heterogeneity of protein kinase C and its implications for cellular regulation , 1988, Nature.

[6]  W. Wilkison,et al.  Altered growth regulation and enhanced tumorigenicity of NIH 3T3 fibroblasts transfected with protein kinase C-I cDNA , 1988, Cell.

[7]  Mark D. Johnson,et al.  Overproduction of protein kinase C causesdisordered growth control in rat fibroblasts , 1988, Cell.

[8]  I. Pastan,et al.  Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene. , 1987, Science.

[9]  I. Weinstein,et al.  Isolation of cDNA clones encoding protein kinase C: evidence for a protein kinase C-related gene family. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[10]  A. Ullrich,et al.  Multiple, distinct forms of bovine and human protein kinase C suggest diversity in cellular signaling pathways. , 1986, Science.

[11]  A. Ullrich,et al.  The complete primary structure of protein kinase C--the major phorbol ester receptor. , 1986, Science.

[12]  Y. Nishizuka.  Studies and perspectives of protein kinase C. , 1986, Science.

[13]  I. Pastan,et al.  Epidermal growth factor regulates the expression of its own receptor. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[14]  W. Wharton,et al.  Multistep change in epidermal growth factor receptors during spontaneous neoplastic progression in Chinese hamster embryo fibroblasts. , 1985, Cancer research.

[15]  Hermona Soreq,et al.  Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin , 1985, Nature.

[16]  R. Evans,et al.  Expression cloning of human EGF receptor complementary DNA: gene amplification and three related messenger RNA products in A431 cells. , 1984, Science.

[17]  Y H Xu,et al.  Amplification and enhanced expression of the epidermal growth factor receptor gene in A431 human carcinoma cells. , 1984, Science.

[18]  M. James,et al.  Characterization of a specific phorbol ester aporeceptor in mouse brain cytosol. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[19]  D. Baltimore,et al.  Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus , 1983, Cell.

[20]  Y Nishizuka,et al.  Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. , 1982, The Journal of biological chemistry.

[21]  G. Todaro,et al.  Biologically active phorbol esters specifically alter affinity of epidermal growth factor membrane receptors , 1979, Nature.

[22]  G. Todaro,et al.  Transformation by murine and feline sarcoma viruses specifically blocks binding of epidermal growth factor to cells , 1976, Nature.